- Filed
- Mar 24, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Mar 24, 2022 | 93.73M sh |
| Current Liabilities | Q3 2021 · Jan 31, 2022 | $35.9M |
| Current Liabilities | Q3 2021 · Apr 30, 2021 | $34.96M |
| Total Liabilities | Q3 2021 · Jan 31, 2022 | $35.9M |
| Total Liabilities | Q3 2021 · Apr 30, 2021 | $34.97M |
| Current Assets | Q3 2021 · Jan 31, 2022 | $108.82K |
| Current Assets | Q3 2021 · Apr 30, 2021 | $182.47K |
| Total Assets | Q3 2021 · Jan 31, 2022 | $2.06M |
| Total Assets | Q3 2021 · Apr 30, 2021 | $2.15M |
| Eps Diluted | Q3 2021 · Jan 31, 2022 | $0.00 |
| Eps Diluted | Q3 2021 · Jan 31, 2022 | −$0.01 |
| Eps Diluted | Q3 2021 · Jan 31, 2021 | −$0.01 |
| Eps Diluted | Q3 2021 · Jan 31, 2021 | −$0.04 |
| Net Income | Q3 2021 · Apr 30, 2021 | −$1.24M |
| Net Income restated | Q3 2021 · Jan 31, 2021 | −$2.51M |
| Net Income | Q3 2021 · Jan 31, 2021 | −$3.66M |
| Net Income | Q3 2021 · Oct 31, 2020 | −$1.2M |
| Net Income | Q3 2021 · Jul 31, 2020 | −$1.18M |
| Operating Cash Flow | Q3 2021 · Jan 31, 2021 | −$902.33K |
| Cash And Equivalents | Q3 2021 · Jan 31, 2021 | $194.67K |
| Cash And Equivalents | Q3 2021 · Apr 30, 2020 | $347.89K |
| Stockholders Equity restated | Q3 2021 · Jan 31, 2021 | −$31.49M |
| Stockholders Equity restated | Q3 2021 · Oct 31, 2020 | −$30.13M |
| Stockholders Equity | Q3 2021 · Jul 31, 2020 | −$28.84M |
| Stockholders Equity restated | Q3 2021 · Apr 30, 2020 | −$27.58M |
| Sga Expense | Q3 2021 · Jan 31, 2021 | $51.28K |
| Sga Expense | Q3 2021 · Jan 31, 2021 | $151.81K |